KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 162 filers reported holding KRYSTAL BIOTECH INC in Q1 2023. The put-call ratio across all filers is 1.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,887,807 | -24.2% | 101,259 | -48.3% | 0.93% | -34.0% |
| Q1 2023 | $15,690,159 | -58.2% | 195,980 | -58.6% | 1.41% | -59.4% |
| Q4 2022 | $37,525,801 | +9.3% | 473,691 | -3.8% | 3.48% | +0.3% |
| Q3 2022 | $34,331,000 | -12.2% | 492,555 | -17.3% | 3.47% | -23.7% |
| Q2 2022 | $39,108,000 | -18.1% | 595,612 | -17.0% | 4.55% | +8.0% |
| Q1 2022 | $47,771,000 | +0.4% | 717,936 | +5.6% | 4.21% | +23.7% |
| Q4 2021 | $47,578,000 | +43.9% | 680,170 | +7.4% | 3.41% | +56.4% |
| Q3 2021 | $33,074,000 | -7.6% | 633,481 | +20.3% | 2.18% | +1.4% |
| Q2 2021 | $35,812,000 | -5.4% | 526,650 | +7.1% | 2.15% | -14.5% |
| Q1 2021 | $37,866,000 | +28.3% | 491,511 | -0.0% | 2.51% | +15.0% |
| Q4 2020 | $29,504,000 | +47.5% | 491,740 | +5.8% | 2.18% | +6.5% |
| Q3 2020 | $20,004,000 | +4.0% | 464,663 | +0.1% | 2.05% | -8.5% |
| Q2 2020 | $19,226,000 | – | 464,179 | – | 2.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $53,700,000 | 4.14% |
| S Squared Technology, LLC | 85,215 | $5,113,000 | 2.93% |
| First Light Asset Management, LLC | 491,740 | $29,504,000 | 2.18% |
| Redmile Group, LLC | 1,675,036 | $100,502,000 | 1.22% |
| Nicholas Investment Partners, LP | 233,543 | $14,013,000 | 1.08% |
| HighMark Wealth Management LLC | 17,586 | $1,055,000 | 0.91% |
| DSAM Partners (London) Ltd | 87,608 | $5,256,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 101,044 | $6,063,000 | 0.54% |
| Hood River Capital Management LLC | 261,122 | $15,667,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 9,900 | $594,000 | 0.45% |